Lv4
531 积分 2021-02-20 加入
Effectiveness and safety of BCD180, anti-TRBV9<sup>+</sup> T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA
25天前
已完结
Imlifidase: First Approval
25天前
已完结
HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity
1个月前
已完结
Recent Advances in the Immunopathology of Axial Spondyloarthritis: with and without HLA-B27
1个月前
已完结
The Efficacy and Safety of BCD-180, an Anti-TRBV9+ T cell Monoclonal Antibody, in Patients with Active Radiographic Axial Spondyloarthritis: 36-week Results from the Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study ELEFTA
1个月前
已完结
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
1个月前
已完结
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I NSCLC
1个月前
已完结
Overcoming TGFβ-mediated immune evasion in cancer
1个月前
已完结
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?
2个月前
已完结
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer
皖公网安备34019202002308
